| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 2,422,200 | 2,403,900 | 2,333,300 | 2,615,200 | | Cost of Revenue | 1,041,200 | 1,043,400 | 1,043,500 | 1,196,800 | | | Gross Profit | 1,381,000 | 1,360,500 | 1,289,800 | 1,418,400 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,039,300 | 1,000,900 | 987,900 | 1,114,400 | | Non Recurring | 131,600 | 21,900 | 126,900 | 52,000 | | Others | 132,600 | 133,700 | 134,100 | 134,300 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 199,400 | 204,000 | 40,900 | 117,700 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 17,900 | 21,900 | 2,900 | (6,400) | | Earnings Before Interest And Taxes | 217,300 | 225,900 | 43,800 | 111,300 | | Interest Expense | 8,600 | 8,600 | 8,900 | 13,000 | | Income Before Tax | 208,700 | 217,300 | 34,900 | 98,300 | | Income Tax Expense | 58,700 | 65,800 | 9,900 | 34,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 271,900 | 151,500 | 25,000 | 64,300 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 150,000 | 151,500 | 25,000 | 64,300 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $150,000 | $151,500 | $25,000 | $64,300 |
|
0.03% Nasdaq 
0.20 (0.85%) 
Income Statement
